YU5296A - Proteini protiv gojaznosti - Google Patents
Proteini protiv gojaznostiInfo
- Publication number
- YU5296A YU5296A YU5296A YU5296A YU5296A YU 5296 A YU5296 A YU 5296A YU 5296 A YU5296 A YU 5296A YU 5296 A YU5296 A YU 5296A YU 5296 A YU5296 A YU 5296A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- obesity
- patients
- agents
- obesity proteins
- proteins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Dati pronalazak definiše proteine koji se koriste kao agensi protiv gojaznosti, i koji kada se daju pacijentima reguliše njihovo masno tkivo. Saglasno gore navedenome ovakvi agensi omogućavaju pacijentima da prevazidju njihove hendikepe sa preteranom gojaznošću odnosno značajno im smanjuje rizik od dijabetisa tipa II kao i od kardiovaskularnih oboljenja i kancera.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38104895A | 1995-01-31 | 1995-01-31 | |
US38363895A | 1995-02-06 | 1995-02-06 | |
US45095P | 1995-06-22 | 1995-06-22 | |
US216195P | 1995-08-11 | 1995-08-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU5296A true YU5296A (sh) | 1998-08-14 |
Family
ID=27484996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU5296A YU5296A (sh) | 1995-01-31 | 1996-01-29 | Proteini protiv gojaznosti |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPH10513451A (sh) |
KR (1) | KR19980701798A (sh) |
AR (1) | AR002956A1 (sh) |
AU (1) | AU703316B2 (sh) |
BR (1) | BR9606999A (sh) |
CA (1) | CA2211784A1 (sh) |
CO (1) | CO4480035A1 (sh) |
CZ (1) | CZ240497A3 (sh) |
FI (1) | FI973162A (sh) |
NO (1) | NO973515L (sh) |
NZ (1) | NZ301589A (sh) |
PE (1) | PE15197A1 (sh) |
PL (1) | PL321702A1 (sh) |
TR (1) | TR199600085A2 (sh) |
YU (1) | YU5296A (sh) |
-
1996
- 1996-01-29 CZ CZ972404A patent/CZ240497A3/cs unknown
- 1996-01-29 CA CA002211784A patent/CA2211784A1/en not_active Abandoned
- 1996-01-29 PL PL96321702A patent/PL321702A1/xx unknown
- 1996-01-29 KR KR1019970705195A patent/KR19980701798A/ko not_active Application Discontinuation
- 1996-01-29 YU YU5296A patent/YU5296A/sh unknown
- 1996-01-29 NZ NZ301589A patent/NZ301589A/xx unknown
- 1996-01-29 BR BR9606999A patent/BR9606999A/pt not_active Application Discontinuation
- 1996-01-29 CO CO96003533A patent/CO4480035A1/es unknown
- 1996-01-29 AU AU47052/96A patent/AU703316B2/en not_active Withdrawn - After Issue
- 1996-01-29 JP JP8523612A patent/JPH10513451A/ja active Pending
- 1996-01-30 AR ARP960101202A patent/AR002956A1/es unknown
- 1996-01-30 PE PE1996000072A patent/PE15197A1/es not_active Application Discontinuation
- 1996-01-31 TR TR96/00085A patent/TR199600085A2/xx unknown
-
1997
- 1997-07-30 NO NO973515A patent/NO973515L/no not_active Application Discontinuation
- 1997-07-30 FI FI973162A patent/FI973162A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
CZ240497A3 (cs) | 1998-01-14 |
AU703316B2 (en) | 1999-03-25 |
CO4480035A1 (es) | 1997-07-09 |
KR19980701798A (ko) | 1998-06-25 |
JPH10513451A (ja) | 1998-12-22 |
PL321702A1 (en) | 1997-12-22 |
NZ301589A (en) | 1999-02-25 |
BR9606999A (pt) | 1997-10-28 |
NO973515D0 (no) | 1997-07-30 |
TR199600085A2 (tr) | 1996-08-21 |
PE15197A1 (es) | 1997-05-22 |
CA2211784A1 (en) | 1996-08-08 |
AR002956A1 (es) | 1998-05-27 |
FI973162A (fi) | 1997-09-30 |
NO973515L (no) | 1997-09-29 |
FI973162A0 (fi) | 1997-07-30 |
AU4705296A (en) | 1996-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001096587A3 (en) | Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus | |
TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
DE69526120T2 (de) | Verwendung von nebivolol als anti-atherogenisches mittel | |
MXPA03006771A (es) | Anticuerpos modificados y metodos de uso. | |
BR0316050A (pt) | Métodos de tratar, controlar ou prevenir um câncer especìfico e doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com terapia de radiação, terapia hormonal, terapia biológica, ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit | |
ATE322902T1 (de) | Verwendung von azetogenischen hydrogenotrophischen stämmen zur vorbeugung und behandlung von verdauungskrankheiten | |
DE60001271D1 (de) | Hydroxymatairesinol in der krebs-prevention | |
ATE185149T1 (de) | Immunogene verbindungen mit spezifischem anti- cytokin effekt, methode zur herstellung, pharmazeutische zusammensetzung und reaktionskit der diese enthält | |
DE59811158D1 (de) | Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen | |
MX9602689A (es) | Usos terapeuticos humanos de los productos de proteina bpi. | |
ATE450622T1 (de) | Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit | |
ATE307886T1 (de) | Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung | |
ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
DK0777499T3 (da) | Levende vaccine til behandling af tumorsygdomme | |
FR2746110B1 (fr) | Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants | |
YU5296A (sh) | Proteini protiv gojaznosti | |
AU2002251754A1 (en) | Therapeutic modulation of the tumor inflammatory response | |
AU6987696A (en) | The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells | |
BR9708005A (pt) | C3 convertase resistente à regulação para baixo | |
DE69804466T2 (de) | Robinia pseudoacacia lektin und seine verwendungen | |
DE69712907D1 (de) | Immunogene tlp-zusammensetzung | |
PT883406E (pt) | Utilizacao da il-7 no tratamento das doencas auto-imunes em particular a diabetes mellitus insulinodependente | |
ATE363072T1 (de) | Monoklonaler antikörper gegen mxa und mxb | |
KR927003083A (ko) | 인간 인터류킨 2 활성을 갖는 폴리펩티드 기재의 항종양제 조성물 | |
ES2160927T3 (es) | Composiciones farmaceuticas que comprenden interferon alfa humano natural. |